β-Klotho基因变异与儿童NAFLD肝损伤相关
本研究在249例经活检证实的儿童NAFLD患者中评估了KLB rs17618244 G>A变异对肝损伤的影响及其与肝脏和可溶性KLB表达的关系,并通过体外模型探究突变型KLB的作用。结果发现该变异与气球样变和小叶内炎症风险增加相关,携带A等位基因者血浆KLB水平较低且与组织学损伤相关;体外实验显示游离脂肪酸降低KLB表达,KLB突变导致脂质积累和炎症基因上调。结论提示KLB蛋白可能对肝细胞脂毒性和炎症发挥保护作用。
要点
- KLB rs17618244变异与儿童NAFLD气球样变和小叶内炎症风险增加相关。
- 携带A等位基因者血浆KLB水平较低,且与小叶内炎症、气球样变和纤维化相关。
- 体外实验提示KLB下调可导致肝细胞脂质积累和炎症基因表达上调。
核心结论
- KLB rs17618244变异导致KLB表达降低,与儿童NAFLD严重程度相关。
- KLB蛋白可能对肝细胞脂毒性和炎症发挥保护作用。
研究设计与样本
- 研究纳入249例经活检证实的儿童NAFLD患者,评估KLB rs17618244变异对肝损伤的影响及其与肝脏和可溶性KLB表达的关系。
- 建立体外模型(HepG2和Huh7细胞系)探究KLB突变的作用。
主要发现
- KLB rs17618244变异与气球样变和小叶内炎症风险增加相关。
- 携带rs17618244 minor A等位基因者血浆KLB水平较低,且与小叶内炎症、气球样变和纤维化相关。
- 在HepG2和Huh7细胞中,游离脂肪酸暴露导致细胞内和分泌型KLB严重减少。
- 在HepG2和Huh7细胞中表达KLB突变体下调KLB,诱导细胞内脂质积累并上调p62、ACOX1、ACSL1、IL-1β和TNF-α基因表达。
临床怎么用
- KLB rs17618244变异及血浆KLB水平可能有助于评估儿童NAFLD患者肝损伤严重程度。
- KLB通路可能成为儿童NAFLD的潜在治疗靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIM: Non-alcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease in adults and children. Along with obesity, diabetes and insulin resistance, genetic factors strongly impact on NAFLD development and progression. Dysregulated bile acid metabolism and the fibroblast growth factor 19 (FGF19) pathway play a pivotal role in NAFLD pathogenesis. However, the mechanism through which the FGF19 receptor system is associated with liver damage in NAFLD remains to be defined. METHODS: We evaluated the impact of the rs17618244 G>A β-Klotho (KLB) variant on liver damage in 249 pediatric patients with biopsy-proven NAFLD and the association of this variant with the expression of hepatic and soluble KLB. In vitro models were established to investigate the role of the KLB mutant. RESULTS: The KLB rs17618244 variant was associated with an increased risk of ballooning and lobular inflammation. KLB plasma levels were lower in carriers of the rs17618244 minor A allele and were associated with lobular inflammation, ballooning and fibrosis. In HepG2 and Huh7 hepatoma cell lines, exposure to free fatty acids caused a severe reduction of intracellular and secreted KLB. Finally, KLB downregulation obtained by the expression of a KLB mutant in HepG2 and Huh7 cells induced intracellular lipid accumulation and upregulation of p62, ACOX1, ACSL1, IL-1β and TNF-α gene expression. CONCLUSION: In conclusion, we showed an association between the rs17618244 KLB variant, which leads to reduced KLB expression, and the severity of NAFLD in pediatric patients. We can speculate that the KLB protein may exert a protective role against lipotoxicity and inflammation in hepatocytes. LAY SUMMARY: Genetic and environmental factors strongly impact on the pathogenesis and progression of non-alcoholic fatty liver disease (NAFLD). The FGF19/FGFR4/KLB pathway plays a pivotal role in the pathogenesis of NAFLD. The aim of the study was to investigate the impact of a genetic variant in the KLB gene on the severity of liver disease. Our data suggest that the KLB protein plays a protective role against lipotoxicity and inflammation in hepatocytes.
引用
- Dongiovanni P, Crudele A, Panera N, et al. β-Klotho gene variation is associated with liver damage in children with NAFLD. J Hepatol. 2019. PMID: 31655133. doi:10.1016/j.jhep.2019.10.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。